Nano and surface plasmonics were used to probe multiple myeloma (MM) exosomes.
Nanoplasmonics probed that MM patients count four folds more exosomes than healthy.
Nanoplasmonic titration allowed for controlled SPR biosensing experiments.
SPR biosensing showed that MM exosomes have a distinctive affinity for heparin.